Herpes-virus infection in patients with Langerhans cell histiocytosis: A case-controlled sero-epidemiological study, and in situ analysis

PLoS ONE

Volumn 3, Issue 9, 2008, Pages

  Jeziorski, Eric ^a   Senechal, Brigitte ^a   Molina, Thierry Jo ^a,b   Devez, Francis ^b   Leruez Ville, Marianne ^c   Morand, Patrice ^d   Glorion, Christophe ^c   Mansuy, Ludovic ^e   Gaudelus, Joel ^f   Debre, Marianne ^c   Jaubert, Francis ^a,c   Seigneurin, Jean Marie ^d   Thomas, Caroline ^g   Joab, Irene ^h   Donadieu, Jean ⁱ   Geissmann, Frederic ^a,c  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d HÔPITAL MICHALLON   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f HÔPITAL JEAN VERDIER   (France)

^g NANTES UNIVERSITY HOSPITAL   (France)

^h UNIVERSITÉ PARIS SACLAY   (France)

ⁱ ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD20 ANTIGEN; CD79 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; T6 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BIOSYNTHESIS; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HERPES VIRUS INFECTION; HISTIOCYTOSIS X; HUMAN; HUMAN HERPESVIRUS 6; INFANT; METABOLISM; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; ADULT; ANTIGENS, CD1; ANTIGENS, CD20; ANTIGENS, CD79; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYTOMEGALOVIRUS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT;

EID: 54749147516     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003262     Document Type: Article

References (47)

1. Lichtenstein L (1953) Histiocytosis X; integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schuller-Christian disease as related manifestations of a single nosologic entity. AMA Arch Pathol 56: 84-102.
2. French Histiocytosis study group (1996) A multicentre retrospective survey of Langerhans' cell histiocylosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group. Arch Dis Child 75: 17-24.
3. Ladisch S (1998) Langerhans cell histiocytosis. Curr Opin Hematol 5: 54-58.
4. Laman JD, Leenen PJ, Annels NE, Hogendoorn PC, Egeler RM (2003) Langerhans-cell histiocytosis 'insight into DC biology'. Trends Immunol 24: 190-196.
5. Geissmann F, Lepelletier Y, Fraitag S, Valladeau J, Bodemer C, et al. (2001) Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 97: 1241-1248.
6. Roncarolo MG, Levings MK, Traversari C (2001) Differentiation of T regulatory cells by immature dendritic cells. J Exp Med 193: F5-9.
7. Mahnke K, Knop J, Enk AH (2003) Induction of tolerogenic DCs: 'you are what you eat'. Trends Immunol 24: 646-651.
8. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, et al. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194: 769-779.
9. Steinman RM, Nussenzweig MC (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 99: 351-358.
10. Senechal B, Elain G, Jeziorski E, Grondin V, Patey-Mariaud de Serre N, et al. (2007) Expansion of regulatory T cells in patients with langerhans cell histiocytosis. PLoS Med 4: e253.
11. Chen CJ, Ho TY, Lu JJ, Sheu LF, Lee SY, et al. (2004) Identical twin brothers concordant for Langerhans' cell histiocytosis and discordant for Epstein-Barr virus-associated haemophagocytic syndrome. Eur J Pediatr 163: 536-539.
12. Sakata N, Toguchi N, Kimura M, Nakayama M, Kawa K, et al. (2007) Development of Langerhans cell histiocytosis associated with chronic active Epstein-Barr virus infection. Pediatr Blood Cancer.
13. Purtilo DT (1980) Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals. Lancet 1: 300-303.
14. Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768.
15. Menasche G, Feldmann J, Fischer A, de Saint Basile G (2005) Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev 203: 165-179.
16. Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, et al. (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444: 110-114.
17. Tugizov S, Herrera R, Veluppillai P, Greenspan J, Greenspan D, et al. (2007) Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal eipthelium. J Virol 81: 5484-5496.
18. Walling DM, Ray AJ, Nichols JE, Flaitz CM, Nichols CM (2007) Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation. J Virol 81: 7249-7268.
19. Shimakage M, Sasagawa T, Kimura M, Shimakage T, Seto S, et al. (2004) Expression of Epstein-Barr virus in Langerhans' cell histiocytosis. Hum Pathol 35: 862-868.
20. McClain K, Jin H, Gresik V, Favara B (1994) Langerhans cell histiocytosis: lack of a viral etiology. Am J Hematol 47: 16-20.
21. Schenka AA, De Angelo Andrade LA, Amstalden EM, Cintra ML, Vassallo J, et al. (2006) Langerhans cell histiocytosis and its relationship with Epstein-Barr virus. Hum Pathol 37: 1508-1509; author reply 1509-1511.
22. Brousset P (2004) Epstein-Barr virus and Langerhans cell histiocytosis. Hum Pathol 35: 1573-1574; author reply 1574.
23. Hertel L, Lacaille VG, Strobl H, Mellins ED, Mocarski ES (2003) Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol 77: 7563-7574.
24. Lee AW, Hertel L, Louie RK, Burster T, Lacaille V, et al. (2006) Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. J Immunol 177: 3960-3971.
25. Senechal B, Boruchov AM, Reagan JL, Hart DN, Young JW (2004) Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 103: 4207-4215.
26. Kawakubo Y, Kishimoto H, Sato Y, Yanagimoto K, Tsuruta T, et al. (1999) Human cytomegalovirus infection in foci of Langerhans cell histiocytosis. Virchows Arch 434: 109-115.
27. Kondo K, Kondo T, Okuno T, Takahashi M, Yamanishi K (1991) Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 72 (Pt 6): 1401-1408.
28. Kondo K, Kondo T, Shimada K, Amo K, Miyagawa H, et al. (2002) Strong interaction between human herpesvirus 6 and peripheral blood monocytes/ macrophages during acute infection. J Med Virol 67: 364-369.
29. Leahy MA, Krejci SM, Friednash M, Stockert SS, Wilson H, et al. (1993) Human herpesvirus 6 is present in lesions of Langerhans cell histiocytosis. J Invest Dermatol 101: 642-645.
30. Glotzbecker MP, Carpentieri DF, Dormans JP (2004) Langerhans cell histiocytosis: a primary viral infection of bone? Human herpes virus 6 latent protein detected in lymphocytes from tissue of children. J Pediatr Orthop 24: 123-129.
31. Glotzbecker MP, Dormans JP, Pawel BR, Wills BP, Joshi Y, et al. (2006) Langerhans cell histiocytosis and human herpes virus 6 (HHV-6), an analysis by real-time polymerase chain reaction. J Orthop Res 24: 313-320.
32. de-The G, Geser A, Day NE, Tukei PM, Williams EH, et al. (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274: 756-761.
33. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, et al. (1989) Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 320: 689-695.
34. Besson C, Amiel C, Le-Pendeven C, Brice P, Ferme C, et al. (2006) Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives. J Clin Microbiol 44: 47-50.
35. Leruez-Ville M, Ouachee M, Delarue R, Sauget AS, Blanche S, et al. (2003) Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma. J Clin Microbiol 41: 2040-2046.
36. Balfour HH Jr., Holman CJ, Hokanson KM, Lelonek MM, Giesbrech JE, et al. (2005) A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis 192: 1505-1512.
37. Ward KN, Leong HN, Thiruchelvam AD, Atkinson CE, Clark DA (2007) Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol 45: 1298-1304.
38. Achour A, Boutolleau D, Slim A, Agut H, Gautheret-Dejean A (2007) Human herpesvirus-6 (HHV-6) DNA in plasma reflects the presence of infected blood cells rather than circulating viral particles. J Clin Virol 38: 280-285.
39. Leong HN, Tuke PW, Tedder RS, Khanom AB, Eglin RP, et al. (2007) The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors. J Med Virol 79: 45-51.
40. Lewin N, Aman P, Masucci MG, Klein E, Klein G, et al. (1987) Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int J Cancer 39: 472-476.
41. Wagner HJ, Bein G, Bitsch A, Kirchner H (1992) Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J Clin Microbiol 30: 2826-2829.
42. Khanna R, Burrows SR, Moss DJ (1995) Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev 59: 387-405.
43. Slacmeulder M, Geissmann F, Lepelletier Y, Fournet JC, Brousse N, et al. (2002) No association between Langerhans cell histiocytosis and human herpes virus 8. Med Pediatr Oncol 39: 187-189.
44. Jenson HB, McClain KL, Leach CT, Deng JH, Gao SJ (2000) Evaluation of human herpesvirus type 8 infection in childhood langerhans cell histiocytosis. Am J Hematol 64: 237-241.
45. Henderson A, Ripley S, Heller M, Kieff E (1983) Chromosome site for Epstein-Barr virus DNA in a Burkitt rumor cell line and in lymphocytes growth-transformed in vitro. Proc Natl Acad Sci U S A 80: 1987-1991.
46. Brengel-Pesce K, Morand P, Schmuck A, Bourgeat MJ, et al. (2002) Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J Med Virol 66: 360-9.
47. Gautheret-Dejean A, Manichanh C, Thien-Ah-Koon F, Fillet AM, Mangeney N, et al. (2002) Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods 100: 27-35.